A collection of more than 50 LGBTQ, public health and HIV/AIDS activists have signed a joint letter urging Facebook to remove advertisements from its platform that they say are “factually inaccurate” and scare at-risk users away from pre-exposure prophylaxis (PrEP) treatments.
These ads — which the signatory groups say are being directed at LGBTQ Facebook and Instagram users — come from multiple...
A new study conducted at Brigham and Women’s Hospital in Boston in partnership with The Fenway Institute at Fenway Health will be using eTectRx’s ingestion event monitoring system to research adherence of the HIV prevention drug Truvada for pre-exposure prophylaxis (PrEP).
PrEP is a preventative drug designed to be taken by people who do not have HIV but are at risk for the condition. and must...
Proteus Digital Health’ pitch to track adherence using sensor-equipped pills has found another audience in the HIV prevention community.
Among the featured data presented at this week’s International AIDS Conference in Amsterdam was a trial that outfitted Gilead Sciences’ preventive HIV drug Truvada (tenofovir/emtricitabine) with the tracking technology. Here, researchers found that the sensor-...
